Top Markets
Coin of the day
Therma Bright Inc. Therma Bright Inc.

Therma Bright Inc.

THRM
Peringkat dalam Saham #36876
Established in Toronto, Canada, in 2001 as The Jenex Corporation before... Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerings include rapid COVID-19 diagnostic tests like AcuVid, which screens for both antigens and antibodies. For pain relief, they provide devices such as Benepod, a hot and cold contrast therapy system designed to manage discomfort without medication. The company also addresses circulatory issues with Venowave, a medical compression pump aimed at mitigating symptoms associated with poor circulation. Furthermore, Therma Bright caters to the cosmeceutical industry with products like InterceptCS, a cold sore prevention system utilizing safe, controlled topical heat, and TherOZap, a thermal device that alleviates the pain, itching, and inflammation from insect bites and stings by reducing the inflammatory response. Their clientele spans both individual consumers and healthcare practitioners.
Harga Saham
$0.03669684
Terakhir disinkronkan: 2026-08-13
Kapitalisasi Pasar
$2.25M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-27.55%
Negara
CA
Perdagangan Therma Bright Inc. (THRM)

Kategori

Laba untuk Therma Bright Inc. (THRM)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Therma Bright Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Therma Bright Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US